Shi Y, Tu L X, Deng Q, Zhang Y P, Hu Y H, Liu D W
Department of Plastic and Aesthetic Surgery, Maternal and Child Health Hospital Affiliated to Nanchang University, Jiangxi Maternal and Child Health Hospital, Nanchang 330006, China.
Department of Burns, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zhonghua Shao Shang Za Zhi. 2020 Mar 20;36(3):195-203. doi: 10.3760/cma.j.cn501120-20191125-00441.
To explore the effects and mechanism of rat epidermal stem cells (ESCs) that were treated with exogenous vascular endothelial growth factor (VEGF) on the healing of deep partial-thickness burn wounds in rats. ESCs were isolated and cultured from the trunk skin of a 3-month-old female Sprague-Dawley (SD) rat. The third passage of cultured cells in the logarithmic growth phase was used in experiments (1)-(3). (1) The cells were routinely cultured in keratinocytes-specified serum-free medium (K-SFM) (the same routine culture condition below). The morphology of cells cultured for 3 and 5 days was observed under the inverted optical microscope. (2) After 24 hours in routine culture, the expression of cell surface markers CD44, CD45, CD11b, and CD11c was detected by flow cytometer, with triplicate samples. (3) Four batches of cells were collected, and each batch was divided into VEGF group or blank control group according to the random number table. The cells in blank control group were routinely cultured, while the cells in VEGF group were cultured in K-SFM containing VEGF in the final mass concentration of 10 ng/mL. The protein expressions of cytokeratin 19 (CK19) and CK10 in cells cultured for 10 days were detected by Western blotting. The Nanog mRNA expression in cells cultured for 0 (immediately), 2, 4, 6, 8, and 10 day (s) was detected by real-time fluorescent quantitative reverse transcription polymerase chain reaction. The absorbance value was detected with cell counting kit-8 in cells cultured for 2, 4, 6, 8, and 10 days. The clone number of more than 50 cells was observed and counted under the optical microscope in cells cultured for 10 days, and the cell colony formation rate was calculated. Three samples at each time point was analysed. (4) Thirty-six 3-month-old SD rats (either male or female) were used for the study, and two deep partial-thickness burn wounds (10 mm in diameter) were created in each rat by pressing a 100 ℃ electric iron plate on symmetric dorsal side. According to the random number table, the injured rats were divided into VEGF+ ESCs group, ESCs alone group, and blank control group, with 12 rats and 24 wounds in each group. From 0 (immediately) to 2 day (s) after injury, 20 μL phosphate buffer solution (PBS) was injected into each wound in the three groups in one time, once a day, with the solution in VEGF+ ESCs group containing 0.8×10(6) cells/mL of ESCs treated by 10 ng/mL VEGF for 10 days, the solution in ESCs alone group containing 0.8×10(6) cells/mL of ESCs without any treatment, and the solution in blank control group being PBS only. On post first injection day (PFID) 0 (immediately), 3, 7, and 14, three rats from each group were taken respectively according to the random number table for wound healing assessment, and the wound healing rates on PFID 3, 7, and 14 were calculated. The mice at each time point were sacrificed with wound tissue harvested for histology, and the skin structure was observed by hematoxylin-eosin staining. Data were statistically analyzed with independent sample test, analysis of variance for factorial design, least significant difference test, and Bonferroni correction. (1) By day 3 in culture, cells distributed in slowly-growing clusters. By day 5, the clusters were large and round, in which the cells mainly with large and round nuclei and little cytoplasm were observed. The above results were consistent with the morphological characteristics of ESCs. (2) The positive expression rate of CD44 was (94.3±1.2) %, and the expressions of CD45, CD11b, and CD11c were negative. The cells were confirmed as ESCs. (3) Compared with those of blank control group, the protein expression of CK19 in the cells of VEGF group was significantly increased after 10 days in culture (=3.756, <0.05), while the protein expression of CK10 was significantly decreased (=3.149, <0.05). Compared with those of blank control group, the Nanog mRNA expression in the cells cultured for 0 and 2 day (s) and absorbance values of the cells cultured for 2 and 4 day (s) were not significantly changed in VEGF group (=0.58, 0.77, 0.53, 3.02, >0.05), while the Nanog mRNA expression in the cells cultured for 4, 6, 8, and 10 days and absorbance values of the cells cultured for 6, 8, and 10 days were significantly increased in VEGF group (=6.34, 5.00, 5.58, 4.61, 5.65, 10.78, 15.51, <0.01). After 10 days in culture, the cell colony-forming rate in VEGF group was (56.4±1.3) %, significantly higher than (31.5±1.3) % of blank control group (=13.96, <0.01). (4) The burn wounds of rats in the three groups were confined to the superficial dermis of the skin on PFID 0. On PFID 3, normal skin tissue at wound margins slightly contracted in the rats of VEGF+ ESCs group, which was earlier than that in the other two groups. On PFID 7, the newly generated epidermis covered most parts of the rat wounds in VEGF+ ESCs group, and some of the epithelium crawled around the rat wounds in ESCs alone group, but no obvious epithelialization was observed in the rat wounds in blank control group. On PFID 14, the rat wounds in VEGF+ ESCs group were basically healed, while some parts of the rat wounds were unhealed in ESCs alone group, and most parts of the rat wounds were unhealed in blank control group. On PFID 3, the wound healing rates of rats in the three groups were similar (>0.05). On PFID 7 and 14, the wound healing rates of rats in ESCs alone group, respectively (26.0±2.0) % and (64.4±4.7) %, were obviously higher than (12.4±1.1) % and (29.1±3.3) % of blank control group (<0.01), all of which were obviously lower than (41.0±2.4) % and (91.3±3.5) % of VEGF+ ESCs group (<0.01). On PFID 3, infiltration of a large number of inflammatory cells were observed in the rat wounds in VEGF+ ESCs group, which was earlier than those in the other two groups. On PFID 7, a large number of endothelial cells were observed in the rat wounds in VEGF+ ESCs group, while proliferation of a few endothelial cells were observed in the rat wounds in ESCs alone group, and a large number of inflammatory cells infiltrated the rat wounds in blank control group. On PFID 14, the newly generated epidermal cells covered nearly all the rat wounds in VEGF+ ESCs group and most parts of the rat wounds in ESCs alone group, while a large number of endothelial cells were observed and the newly generated epidermal cells covered some parts of the rat wounds in blank control group. ESCs of rats treated with exogenous VEGF can promote the healing of deep partial-thickness burn wounds in rats, which may be related to VEGF's roles in promoting the proliferation of ESCs and reducing its differentiation level, so as to maintain the potency of stem cells.
探讨外源性血管内皮生长因子(VEGF)处理的大鼠表皮干细胞(ESCs)对大鼠深Ⅱ度烧伤创面愈合的影响及机制。从3月龄雌性Sprague-Dawley(SD)大鼠的躯干皮肤中分离培养ESCs。将处于对数生长期的第三代培养细胞用于实验(1)-(3)。(1)将细胞常规培养于角质形成细胞专用无血清培养基(K-SFM)中(以下为相同的常规培养条件)。在倒置光学显微镜下观察培养3天和5天的细胞形态。(2)常规培养24小时后,用流式细胞仪检测细胞表面标志物CD44、CD45、CD11b和CD11c的表达,样本重复检测3次。(3)收集四批细胞,根据随机数字表将每批细胞分为VEGF组或空白对照组。空白对照组细胞常规培养,VEGF组细胞在终质量浓度为10 ng/mL的含VEGF的K-SFM中培养。采用蛋白质印迹法检测培养10天的细胞中细胞角蛋白19(CK19)和CK1 Ten的蛋白表达。采用实时荧光定量逆转录聚合酶链反应检测培养0(即刻)、2、4、6、8和10天的细胞中Nanog mRNA的表达。用细胞计数试剂盒-8检测培养2、4、6、8和10天的细胞的吸光度值。在光学显微镜下观察培养10天的细胞中多于50个细胞的克隆数并计数,计算细胞集落形成率。每个时间点分析3个样本。(4)选用36只3月龄SD大鼠(雌雄不限)进行研究,在每只大鼠对称的背部用100℃的电烙铁按压形成两个直径10 mm的深Ⅱ度烧伤创面。根据随机数字表,将受伤大鼠分为VEGF+ESCs组、单纯ESCs组和空白对照组,每组12只大鼠,24个创面。在伤后0(即刻)至2天,三组中每个创面一次性注射20 μL磷酸盐缓冲液(PBS),每天1次,VEGF+ESCs组溶液中含经10 ng/mL VEGF处理10天的ESCs 0.8×10⁶个/mL,单纯ESCs组溶液中含未经任何处理的ESCs 0.8×10⁶个/mL,空白对照组溶液仅为PBS。在首次注射后第0(即刻)、3、7和14天,根据随机数字表从每组中分别取3只大鼠进行创面愈合评估,计算首次注射后第3、7和14天的创面愈合率。每个时间点的小鼠处死后取创面组织进行组织学检查,用苏木精-伊红染色观察皮肤结构。数据采用独立样本t检验、析因设计方差分析、最小显著差检验和Bonferroni校正进行统计学分析。(1)培养至第3天,细胞呈缓慢生长的簇状分布。至第5天,簇变大且呈圆形,其中观察到的细胞主要细胞核大且圆而细胞质少。上述结果与ESCs的形态特征相符。(2)CD44的阳性表达率为(94.3±1.2)%,CD45、CD11b和CD11c的表达均为阴性。细胞被确认为ESCs。(3)培养10天后,与空白对照组相比,VEGF组细胞中CK19的蛋白表达显著增加(t=3.756,P<0.05),而CK10的蛋白表达显著降低(t=3.149,P<0.05)。与空白对照组相比,VEGF组培养0和2天的细胞中Nanog mRNA表达及培养2和4天的细胞吸光度值无显著变化(t=0.58,0.77,0.53,3.02,P>0.05),而培养4、6、8和10天的细胞中Nanog mRNA表达及培养6、8和10天的细胞吸光度值显著增加(t=6.34,5.00,5.58,4.61,5.65,10.78,15.51,P<0.01)。培养10天后,VEGF组细胞集落形成率为(56.4±1.3)%,显著高于空白对照组的(31.5±1.3)%(t=13.96,P<0.01)。(4)三组大鼠的烧伤创面在首次注射后第0天均局限于皮肤的浅真皮层。首次注射后第3天,VEGF+ESCs组大鼠创面边缘的正常皮肤组织略有收缩,早于其他两组。首次注射后第7天,VEGF+ESCs组大鼠创面大部分被新生表皮覆盖,单纯ESCs组大鼠创面有部分上皮细胞沿创面爬行,但空白对照组大鼠创面未观察到明显的上皮化。首次注射后第14天,VEGF+ESCs组大鼠创面基本愈合,单纯ESCs组大鼠创面部分未愈合,空白对照组大鼠创面大部分未愈合。首次注射后第3天,三组大鼠的创面愈合率相似(P>0.05)。首次注射后第7天和14天,单纯ESCs组大鼠的创面愈合率分别为(26.0±2.0)%和(64.4±4.7)%,明显高于空白对照组的(12.4±1.1)%和(29.1±3.3)%(P<0.01),均明显低于VEGF+ESCs组的(41.0±2.4)%和(91.3±3.5)%(P<0.01)。首次注射后第3天,VEGF+ESCs组大鼠创面观察到大量炎性细胞浸润,早于其他两组。首次注射后第7天,VEGF+ESCs组大鼠创面观察到大量内皮细胞,单纯ESCs组大鼠创面观察到少量内皮细胞增殖,空白对照组大鼠创面有大量炎性细胞浸润。首次注射后第14天,VEGF+ESCs组大鼠创面几乎全部被新生表皮细胞覆盖,单纯ESCs组大鼠创面大部分被新生表皮细胞覆盖,空白对照组大鼠创面观察到大量内皮细胞且新生表皮细胞覆盖部分创面。外源性VEGF处理的大鼠ESCs可促进大鼠深Ⅱ度烧伤创面的愈合,这可能与VEGF促进ESCs增殖并降低其分化水平从而维持干细胞的潜能有关。